Compare Aventis Pharma with Fulford India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs FULFORD INDIA - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA FULFORD INDIA SANOFI INDIA/
FULFORD INDIA
 
P/E (TTM) x 41.1 398.8 10.3% View Chart
P/BV x 7.2 6.2 116.0% View Chart
Dividend Yield % 1.2 0.1 1,428.1%  

Financials

 SANOFI INDIA   FULFORD INDIA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
FULFORD INDIA
Mar-14
SANOFI INDIA/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs6,840942 726.1%   
Low Rs4,630450 1,028.9%   
Sales per share (Unadj.) Rs1,203.1691.4 174.0%  
Earnings per share (Unadj.) Rs165.311.5 1,441.9%  
Cash flow per share (Unadj.) Rs209.915.4 1,366.3%  
Dividends per share (Unadj.) Rs84.002.00 4,200.0%  
Dividend yield (eoy) %1.50.3 509.7%  
Book value per share (Unadj.) Rs963.6380.0 253.6%  
Shares outstanding (eoy) m23.033.90 590.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.81.0 473.5%   
Avg P/E ratio x34.760.7 57.1%  
P/CF ratio (eoy) x27.345.3 60.3%  
Price / Book Value ratio x6.01.8 324.9%  
Dividend payout %50.817.4 291.3%   
Avg Mkt Cap Rs m132,0782,714 4,865.8%   
No. of employees `0003.30.4 743.5%   
Total wages/salary Rs m4,068505 805.5%   
Avg. sales/employee Rs Th8,393.86,073.0 138.2%   
Avg. wages/employee Rs Th1,232.41,137.4 108.3%   
Avg. net profit/employee Rs Th1,153.0100.7 1,145.2%   
INCOME DATA
Net Sales Rs m27,7082,696 1,027.6%  
Other income Rs m897125 715.3%   
Total revenues Rs m28,6052,822 1,013.7%   
Gross profit Rs m6,235-46 -13,437.5%  
Depreciation Rs m1,02715 6,756.6%   
Interest Rs m710 73.7%   
Profit before tax Rs m6,09854 11,230.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,29210 23,875.0%   
Profit after tax Rs m3,80645 8,514.5%  
Gross profit margin %22.5-1.7 -1,307.7%  
Effective tax rate %37.617.7 212.6%   
Net profit margin %13.71.7 828.6%  
BALANCE SHEET DATA
Current assets Rs m15,9221,738 916.0%   
Current liabilities Rs m6,235545 1,144.7%   
Net working cap to sales %35.044.3 79.0%  
Current ratio x2.63.2 80.0%  
Inventory Days Days6448 131.3%  
Debtors Days Days214 484.7%  
Net fixed assets Rs m7,53912 63,352.9%   
Share capital Rs m23039 589.7%   
"Free" reserves Rs m21,9621,443 1,522.0%   
Net worth Rs m22,1921,482 1,497.4%   
Long term debt Rs m00-   
Total assets Rs m29,8392,077 1,436.8%  
Interest coverage x872.16.7 12,986.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.91.3 71.5%   
Return on assets %12.82.6 489.6%  
Return on equity %17.23.0 568.6%  
Return on capital %27.54.3 639.0%  
Exports to sales %00-   
Imports to sales %024.5 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA659 0.0%   
Fx inflow Rs m7,58717 44,110.5%   
Fx outflow Rs m7,145673 1,061.4%   
Net fx Rs m442-656 -67.4%   
CASH FLOW
From Operations Rs m3,73990 4,154.4%  
From Investments Rs m-731105 -698.9%  
From Financial Activity Rs m-1,972-14 13,985.8%  
Net Cashflow Rs m1,036181 574.0%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 60.4 75.0 80.5%  
Indian inst/Mut Fund % 14.4 3.8 378.9%  
FIIs % 14.6 0.1 14,600.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 21.2 49.5%  
Shareholders   15,184 4,783 317.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   UNICHEM LAB  AUROBINDO PHARMA  IPCA LABS  WOCKHARDT  VENUS REMEDIES  

Compare SANOFI INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 181 Points Higher; Energy and Healthcare Stocks Witness Buying(Closing)

Indian share markets continued to trade on a positive note during closing hours but ended their session off day's high.

Related Views on News

SANOFI INDIA at All Time High; BSE HEALTHCARE Index Up 0.9% (Market Updates)

Nov 20, 2019 | Updated on Nov 20, 2019

SANOFI INDIA share price has hit an all time high at Rs 7,000 (up 0.6%). The BSE HEALTHCARE Index is up by 0.9%. Among the top gainers in the BSE HEALTHCARE Index today are SANOFI INDIA (up 0.6%) and ABBOTT INDIA (up 0.2%). The top losers include GSK PHARMA and J.B.CHEMICALS (down 0.2%).

GRANULES INDIA at 52 Week High; BSE 500 Index Up 1.0% (Market Updates)

Nov 20, 2019 | Updated on Nov 20, 2019

GRANULES INDIA share price has hit a 52-week high. It is presently trading at Rs 134. BSE 500 Index is up by 0.5% at 15,484. Within the BSE 500, GRANULES INDIA (up 2.5%) and VODAFONE IDEA (up 19.4%) are among the top gainers, while top losers are INDIABULLS INTEGRATED SERVICES and RELIANCE CAPITAL.

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Nov 20, 2019 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 8-QTR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS